1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 FOB Tests
1.2.3 CTC Tests
1.2.4 CEA Tests
1.2.5 Others
1.3 Market by Application
1.3.1 Global Colorectal Cancer Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Diagnostics Market Perspective (2017-2028)
2.2 Colorectal Cancer Diagnostics Growth Trends by Region
2.2.1 Colorectal Cancer Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Colorectal Cancer Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Colorectal Cancer Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Colorectal Cancer Diagnostics Market Dynamics
2.3.1 Colorectal Cancer Diagnostics Industry Trends
2.3.2 Colorectal Cancer Diagnostics Market Drivers
2.3.3 Colorectal Cancer Diagnostics Market Challenges
2.3.4 Colorectal Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Diagnostics Players by Revenue
3.1.1 Global Top Colorectal Cancer Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Colorectal Cancer Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Colorectal Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Diagnostics Revenue
3.4 Global Colorectal Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnostics Revenue in 2021
3.5 Colorectal Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Diagnostics Breakdown Data by Type
4.1 Global Colorectal Cancer Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Colorectal Cancer Diagnostics Forecasted Market Size by Type (2023-2028)
5 Colorectal Cancer Diagnostics Breakdown Data by Application
5.1 Global Colorectal Cancer Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Colorectal Cancer Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Colorectal Cancer Diagnostics Market Size (2017-2028)
6.2 North America Colorectal Cancer Diagnostics Market Size by Type
6.2.1 North America Colorectal Cancer Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Colorectal Cancer Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Colorectal Cancer Diagnostics Market Share by Type (2017-2028)
6.3 North America Colorectal Cancer Diagnostics Market Size by Application
6.3.1 North America Colorectal Cancer Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Colorectal Cancer Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Colorectal Cancer Diagnostics Market Share by Application (2017-2028)
6.4 North America Colorectal Cancer Diagnostics Market Size by Country
6.4.1 North America Colorectal Cancer Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Colorectal Cancer Diagnostics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Colorectal Cancer Diagnostics Market Size (2017-2028)
7.2 Europe Colorectal Cancer Diagnostics Market Size by Type
7.2.1 Europe Colorectal Cancer Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Colorectal Cancer Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Colorectal Cancer Diagnostics Market Share by Type (2017-2028)
7.3 Europe Colorectal Cancer Diagnostics Market Size by Application
7.3.1 Europe Colorectal Cancer Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Colorectal Cancer Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Colorectal Cancer Diagnostics Market Share by Application (2017-2028)
7.4 Europe Colorectal Cancer Diagnostics Market Size by Country
7.4.1 Europe Colorectal Cancer Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Colorectal Cancer Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Colorectal Cancer Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Colorectal Cancer Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Colorectal Cancer Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Diagnostics Market Size (2017-2028)
9.2 Latin America Colorectal Cancer Diagnostics Market Size by Type
9.2.1 Latin America Colorectal Cancer Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Colorectal Cancer Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Colorectal Cancer Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Colorectal Cancer Diagnostics Market Size by Application
9.3.1 Latin America Colorectal Cancer Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Colorectal Cancer Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Colorectal Cancer Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Colorectal Cancer Diagnostics Market Size by Country
9.4.1 Latin America Colorectal Cancer Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Colorectal Cancer Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Colorectal Cancer Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Colorectal Cancer Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Colorectal Cancer Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Details
11.1.2 Biocept Business Overview
11.1.3 Biocept Colorectal Cancer Diagnostics Introduction
11.1.4 Biocept Revenue in Colorectal Cancer Diagnostics Business (2017-2022)
11.1.5 Biocept Recent Developments
11.2 Cancer Genetics
11.2.1 Cancer Genetics Company Details
11.2.2 Cancer Genetics Business Overview
11.2.3 Cancer Genetics Colorectal Cancer Diagnostics Introduction
11.2.4 Cancer Genetics Revenue in Colorectal Cancer Diagnostics Business (2017-2022)
11.2.5 Cancer Genetics Recent Developments
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Details
11.3.2 Foundation Medicine Business Overview
11.3.3 Foundation Medicine Colorectal Cancer Diagnostics Introduction
11.3.4 Foundation Medicine Revenue in Colorectal Cancer Diagnostics Business (2017-2022)
11.3.5 Foundation Medicine Recent Developments
11.4 Sysmex Corporation
11.4.1 Sysmex Corporation Company Details
11.4.2 Sysmex Corporation Business Overview
11.4.3 Sysmex Corporation Colorectal Cancer Diagnostics Introduction
11.4.4 Sysmex Corporation Revenue in Colorectal Cancer Diagnostics Business (2017-2022)
11.4.5 Sysmex Corporation Recent Developments
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Colorectal Cancer Diagnostics Introduction
11.5.4 Danaher Corporation Revenue in Colorectal Cancer Diagnostics Business (2017-2022)
11.5.5 Danaher Corporation Recent Developments
11.6 Epigenomics
11.6.1 Epigenomics Company Details
11.6.2 Epigenomics Business Overview
11.6.3 Epigenomics Colorectal Cancer Diagnostics Introduction
11.6.4 Epigenomics Revenue in Colorectal Cancer Diagnostics Business (2017-2022)
11.6.5 Epigenomics Recent Developments
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Colorectal Cancer Diagnostics Introduction
11.7.4 Illumina Revenue in Colorectal Cancer Diagnostics Business (2017-2022)
11.7.5 Illumina Recent Developments
11.8 Rosetta Genomics
11.8.1 Rosetta Genomics Company Details
11.8.2 Rosetta Genomics Business Overview
11.8.3 Rosetta Genomics Colorectal Cancer Diagnostics Introduction
11.8.4 Rosetta Genomics Revenue in Colorectal Cancer Diagnostics Business (2017-2022)
11.8.5 Rosetta Genomics Recent Developments
11.9 Exact Science Corporation
11.9.1 Exact Science Corporation Company Details
11.9.2 Exact Science Corporation Business Overview
11.9.3 Exact Science Corporation Colorectal Cancer Diagnostics Introduction
11.9.4 Exact Science Corporation Revenue in Colorectal Cancer Diagnostics Business (2017-2022)
11.9.5 Exact Science Corporation Recent Developments
11.10 Pathway Genomics Corporation
11.10.1 Pathway Genomics Corporation Company Details
11.10.2 Pathway Genomics Corporation Business Overview
11.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics Introduction
11.10.4 Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics Business (2017-2022)
11.10.5 Pathway Genomics Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
